| Application no. and date | 19782800.7 (espacenet) (Federated) (European Patent Register), 20190830 | | Patent/reg. no. and date | DK/EP 3844189, 20250122 | | Publication date | 20210707 | | Priority no. and date | US 201862726137 P, 20180831, US 201862774019 P, 20181130, US 201962861100 P, 20190613 | | EP pub. no. and date |
EP 3844189 20210707 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V487834DK00 | | Inventor | LOWY, Israel, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US,
BROWNSTEIN, Carrie, 12 W. 72nd Street, 16D
New York, New York 10023, US,
ADRIAENS, Lieve Lucille, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, New York 10591, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/573 (2006.01) , A61K 39/00 (2006.01) , C07K 16/28 (2006.01) | | Title | Doseringsstrategi, der mindsker cytokinfrigivelsessyndrom for CD3/CD20-bispecifikke antistoffer | | Int. application no. | US2019049027 | | Int. publication no. | WO2020047389 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
